2575.HK
Price:
$8.94
Market Cap:
$4.63B
Xuanzhu Biopharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the research, production, and commercialization of both small-molecule chemical compounds and large-molecule biopharmaceuticals. The company's primary drug candidates include Core- KBP-3571, developed for treating duodenal ulcers; XZP-3287, a CDK4/6 inhibitor aimed at advanced HR+/HER2 breast cancer; and XZP-3621, intended as a first-line therapy for patients suffering from anaplastic lymphoma kinase-positive (ALK+) advanced non-small-cell lung cancer. Its development pipeline further encompasses KM501, a pioneering HER2/HER2 bispecific antibody drug conjugate currently in Phase I clinical trials, alongside KM602, anoth...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2025-10-15
Stock Exchange
HKSE
Ticker
2575.HK
According to Xuanzhubio-b’s latest financial reports and current stock price. The company's current Current Ratio is 3.75. This represents a change of 361.37% compared to the average of 0.81 of the last 4 quarters.
The mean historical Current Ratio of Xuanzhubio-b over the last ten years is 4.54. The current 3.75 Current Ratio has changed 8.17% with respect to the historical average. Over the past ten years (40 quarters), 2575.HK's Current Ratio was at its highest in in the March 2025 quarter at 1.63. The Current Ratio was at its lowest in in the March 2024 quarter at 0.
Average
4.54
Median
3.77
Minimum
2.06
Maximum
8.55
Discovering the peaks and valleys of Xuanzhubio-b Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.33%
Maximum Annual Current Ratio = 8.55
Minimum Annual Increase = -55.68%
Minimum Annual Current Ratio = 2.06
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 3.75 | 82.33% |
| 2024 | 2.06 | -45.69% |
| 2023 | 3.79 | -55.68% |
The current Current Ratio of Xuanzhubio-b (2575.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.20
5-year avg
4.54
10-year avg
4.54
Xuanzhubio-b’s Current Ratio is greater than Livzon Pharmaceutical Group Inc. (1.55), less than China Medical System Holdings Limited (6.64), greater than China Resources Pharmaceutical Group Ltd. (1.43), greater than Grand Pharmaceutical Group Limited (1.34), greater than Genscript Biotech Corporation (1.48), greater than The United Laboratories International Holdings Limited (2.05), greater than Simcere Pharmaceutical Group Limited (1.90), less than HUTCHMED (China) Limited (5.64), greater than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0.20), less than Asymchem Laboratories (Tianjin) Co., Ltd. (4.56),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.55 | $22.71B | |
| 6.64 | $26.23B | |
| 1.43 | $26.70B | |
| 1.34 | $16.58B | |
| 1.48 | $70.70B | |
| 2.05 | $15.64B | |
| 1.90 | $28.38B | |
| 5.64 | $17.78B | |
| 0.20 | $33.07B | |
| 4.56 | $48.42B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xuanzhubio-b using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xuanzhubio-b or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Xuanzhubio-b's Current Ratio?
How is the Current Ratio calculated for Xuanzhubio-b (2575.HK)?
What is the highest Current Ratio for Xuanzhubio-b (2575.HK)?
What is the 3-year average Current Ratio for Xuanzhubio-b (2575.HK)?
What is the 5-year average Current Ratio for Xuanzhubio-b (2575.HK)?
How does the current Current Ratio for Xuanzhubio-b (2575.HK) compare to its historical average?